Patent
1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
| العنوان: | 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
|---|---|
| Patent Number: | 7,645,760 |
| تاريخ النشر: | January 12, 2010 |
| Appl. No: | 10/532331 |
| Application Filed: | October 24, 2003 |
| مستخلص: | A compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein the symbols have meaning as defined, which are antagonists of CCR-1 and which find use pharmaceutically for treatment of diseases and conditions in which CCR-1 is implicated, e.g. inflammatory diseases. [chemical expression included] |
| Inventors: | Bollbuck, Birgit (Weil am Rhein, DE); Eder, Jorg (Rheinfelden, DE); Heng, Richard (Hegenheim, FR); Revesz, Laszio (Therwil, CH); Schlapbach, Achim (Lorrach, DE); Walchli, Rudolf (Basel, CH) |
| Assignees: | Novartis AG. (Based, CH) |
| Claim: | 1. A compound of formula I, or a pharmaceutically acceptable salt or ester thereof, [chemical expression included] wherein R 1 is —X—R 10 , —X—(R 10) 2 or —NR 11 R 12 wherein X is a linker having 1, 2, 3 or 4 atom or independently selected from N, C, or S, and wherein when said linker has 2 or more C atoms the linker may have 1 or more C═C or C≡C bonds; wherein any of said atoms has up to 2 optional substituents selected from hydrogen, oxo, cyano, halo, nitro or optionally substituted oxy, lower alkyl, lower alkyenyl, lower alkynyl, carbonyl, sulfur amino; sulfinyl, sulfonyl; R 10 is optionally substituted and is independently selected from the group consisting of hydrogen, cyano, halo, nitro or optionally substituted oxy, lower alkyl, lower alkyenyl, lower alkynyl, carbonyl, amino, cycloalkyl, heterocycloalkyl, aryl, heteroaryl; R 11 and R 12 are optionally substituted and each represent a lower alkyl group connected together such that R 1 is an optionally substituted heterocycloalkyl or heteroaryl group; R 2 and R 7 are optionally substituted and represent one or more substituents attached to the phenyl ring selected from the group consisting of hydrogen, cyano, halo, nitro or optionally substituted oxy, lower alkyl, lower alkyenyl, lower alkynyl, carbonyl, amino, sulfur, cycloalkyl, heterocycloalkyl, aryl, heteroaryl or a substituent forming a bicyclic ring system of which the phenyl ring to which it is attached forms part of the bicycle for example butadiene forming napthyl, or heterobutadiene forming quinolinyl, quinoxalinyl or isoquinolinyl; R 3 and R 4 are optionally substituted and independently selected from the group consisting of hydrogen, cyano, halo, lower alkyl, lower alkyenyl, lower alkynyl, carbonyl, cycloalkyl, heterocycloalkyl, aryl; R 5 and R 6 are optionally substituted and independently selected from the group consisting of hydrogen; cyano, lower alkyl, lower alkyenyl, lower alkynyl, carbonyl, cycloalkyl, heterocycloalkyl, aryl; the optional substituents on X are one or more independently selected from the group consisting of hydrogen, oxo, cyano, halo, nitro or optionally substituted oxy, lower alkyl, lower alkyenyl, lower alkynyl, lower alkynyl, amino, carbonyl, sulfur, sulfinyl, sulfonyl; wherein the optionally substituted substituents are optionally substituted once or more by a substituent independently selected from the group consisting of hydrogen, oxo, cyano, halo, nitro, oxy, lower alkyl, lower alkyenyl, lower alkynyl, amino, sulfur, cycloalkyl, heterocyloalkyl, aryl; the optional substituents on R 10 are one or more substituents independently selected from the group consisting of hydrogen, oxo, cyano, halo, nitro or optionally substituted oxy, lower alkyl, lower alkyenyl, lower alkynyl, carbonyl, amino, sulfur, cycloalkyl, heterocycloalkyl, aryl; wherein the optionally substituted substituents are optionally substituted once or more by a substituent independently selected from the group consisting of hydrogen, oxo, cyano, halo, nitro or optionally substituted oxy, lower alkyl, lower alkyenyl, lower alkynyl, carbonyl, amino, sulfur, cycloalkyl, heterocycloalkyl, aryl; the optional substituents on R 11 and R 12 are one or more substituents independently selected from the group consisting of hydrogen, oxo, cyano, halo, nitro or optionally substituted oxy, lower alkyl, lower alkyenyl, lower alkynyl, carbonyl, amino, sulfur, cycloalkyl, heterocycloalkyl, aryl; the optional substituents on R 2 and R 7 are one or more substituents independently selected from the group consisting of hydrogen, oxo, cyano, halo, nitro or optionally substituted oxy, lower alkyl, lower alkyenyl, lower alkynyl, carbonyl, amino, sulfur, cycloalkyl, heterocycloalkyl, aryl; wherein the optionally substituted substituents are optionally substituted once or more by a substituent independently selected from the group consisting of hydrogen, oxo, cyano, halo, nitro or optionally substituted oxy, lower alkyl, lower alkyenyl, lower alkynyl, carbonyl, amino, sulfur, cycloalkyl, heterocycloalkyl, aryl; the optional substituents on R 3 and R 4 are one or more substituents independently selected from the group consisting of hydrogen, oxo, cyano, halo, nitro or optionally substituted oxy, lower alkyl, lower alkyenyl, lower alkynyl, carbonyl, amino, sulfur, cycloalkyl, heterocycloalkyl, aryl; wherein the optionally substituted substituents are optionally substituted once or more by a substituent independently selected from the group consisting of hydrogen, oxo, cyano, halo, nitro or optionally substituted oxy, lower alkyl, lower alkyenyl, lower alkynyl, carbonyl, amino, sulfur, cycloalkyl, heterocycloalkyl, aryl; the optional substituents on R 5 and R 6 are one or more substituents independently selected from the group consisting of hydrogen, oxo, cyano, hydroxyl, optionally substituted oxy, lower alkyl, lower alkyenyl, lower alkynyl, carbonyl, cycloalkyl, heterocycloalkyl, aryl, imino, oxime; wherein the optionally substituted substituents are optionally substituted once or more by a substituent independently selected from the group consisting of hydrogen, oxo, hydroxyl, cyano, halo, nitro or optionally substituted oxy, lower alkyl, lower alkyenyl, lower alkynyl, carbonyl, amino, sulfur, cycloalkyl, heterocycloalkyl, or aryl. |
| Claim: | 2. a compound of formula II, or a pharmaceutically acceptable salt or ester thereof, [chemical expression included] wherein R′ 1 is —X′—R′ 10 wherein X′ is a linker independently selected from optionally substituted —N—C—N—, —N—C—, —N—S—, —N—S—N—, —C—N—, —S—N—, —C≡C—, —C═C—, —N—C—S—, —C—, or [chemical expression included] wherein R 2 —R 10 are as herein before defined; R′ 10 is one or more substituents independently selected from the group consisting of hydrogen, halo, optionally substituted methyl, optionally substituted isopropyl, optionally substituted imidazolyl or thiazolyl 3-oxa-1-aza-spiro[4,4]nonan-2-one, hydroxy, optionally substituted pyrrolidinyl, morpholino, piperazinyl, formic acid methyl ester, [1,2,4]triazol, imidazolidinyl, tetrazolyl, —N(CH 3)—OCH 3 or methoxy, optionally substituted carbonyl, amino, heterocycloalkyl and aryl; when R′ 1 is —N—C—N—R′ 10 the C atom is substituted by oxo, ═N—C≡N or ═C—NO 2 ; when R′ 1 is —N—C—N—R′ 10 , R′ 10 is hydrogen; when R′ 1 is —N—C—N—R′ 10 , R′ 10 is optionally substituted by hydrogen; when R′ 1 is —N—C—R′ 10 or —C—N—R′ 10 the C atom is substituted by oxo; when R′ 1 is —N—C—R′ 10 or —C—N—R′ 10 , R′ 10 is optionally substituted methyl, piperidinyl, imidazolidinyl, pyrrolidinyl, morpholino; when R′ 1 is —N—C—R′ 10 or —C—N—R′ 10 , R′ 10 is substituted by hydrogen, methyl, benzyl, acetyl, oxo, dimethylamino, isopropyl, hydroxy, formic acid ethyl ester; when R′ 1 is —N—S—R′ 10 or [chemical expression included] the S atom or atoms are substituted twice by oxo; when R′ 1 is —N—S—R′ 10 or [chemical expression included] R′ 10 is optionally substituted methyl; when R′ 1 is —N—S—R′ 10 or [chemical expression included] R′ 10 is optionally substituted by hydrogen; when R′ 1 is —N—S—N—R′ 10 the S atom is substituted twice by oxo and the N atom is independently optionally substituted by methyl; when R′ 1 is —N—S—N—R′ 10 R′ 10 is hydrogen or optionally substituted methyl, imidazolyl, thiazolyl; when R′ 1 is —N—S—N—R′ 10 , R′ 10 is optionally substituted by hydrogen, methyl, acetamidyl; R′ 1 is —NR″ 11 R″ 12 wherein —NR″ 11 R″ 12 collectively represents imidazolidinyl-2,4-dione, optionally substituted once or twice by a lower alkyl group. |
| Claim: | 3. A compound of formula IIa, or a pharmaceutically acceptable salt or ester thereof, [chemical expression included] wherein N-(5-Chloro-2-[(E)-3-[(R)-4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl]phenyl)-N,N-dimethylsulfamide, N-(5-Chloro-2-[(E)-3-[(R)-4-(4-fluorobenzyl)-2-methylpiperazin-1yl]-3-oxopropenyl]phenyl)-methanesulfonamide, 1-Acetyl-piperidine-4-carboxylic acid (5-chloro-2-{(E)-3-[(R)4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-amide, 1-Methyl-1H-imidazole-4-sulfonic acid(5-Chloro-2-[(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl]-phenyl)-amide, N-(5-(5-Chloro-2-[(E)-3[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl]-phenylsufamoyl)-thiazol-2yl]-acetamide, 2-Oxo-imidazolidine-1-carboxylic acid (5-Chloro-2[(E)-3-[(R)-4-(4-fluoro-benzyl)-7-methyl-piperazin-1-yl]-3oxo-propenyl]-phenyl)-amide, N-(4-Chloro-2-[(E)-3-[4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl]-phenyl)-methylthio-N′-cyano thiourea, N-(4-Chloro-2[(E)-3-[4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl]-phenyl)-sulfonylurea, (5-Chloro-2-[(E)-3-[(2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazin-1-yl]-3-oxopropenyl]-phenyl)-urea, (5-Chloro-2-[(E)-3-[(2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazin-1-yl]-3-oxopropenyl]-phenyl)-urea, N-(5-Chloro-2-[(E)-3-[(2R,5S)-4-(4-fluorobenzyl)-2,5-dimethyl-piperazin-1-yl]-3-oxopropenyl]-phenyl)-acetamide, N-(5-Chloro-2-[(E)-3-[(2S,5R)-4-(4-fluorobenzyl)-2,5-dimethyl-piperazin-1-yl]-3-oxopropenyl]-phenyl)-acetamide, (5-Chloro-2-[(E)-3-[(2S,5R)-4-(4-fluorobenzyl)-2,5-dimethylpiperazin-1-yl]-3-oxopropenyl]-phenyl)-urea, N-(5-Chloro-2-[(E)-3-[-4-(4-fluorobenzyl)-piperazin-1-yl]-3-oxopropenyl)-phenyl)-acetamide, (5-Chloro-2-[(E)-3-[-4-(4-fluorobenzyl)-piperazin-1-yl]-3-oxopropenyl]-phenyl)-urea, (E)-3-[4-Chloro-2-(4-hydroxy-1-methylpiperidin-4-ylethynyl)-phenyl]-1-[(R)-4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-propenone, (E)-3-[4-Chloro-2-(4-hydroxy-1-methylpiperidin-4-ylethynyl)-phenyl]-1-[(S)-4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-propenone, (E)-3-[4-Chloro-2-[(E)-2-(4-hydroxy-1-methylpiperidin-4-yl)-vinyl]-phenyl]-1-[(R)-4-(4-fluorobenzyl)-2methylpiperazin-1-yl]-propenone, (E)-3-[4-Chloro-2-[(E)-2-(4hydroxy-1-methylpiperidin-4-yl)-vinyl]-phenyl]-1[(S)-4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-propenone, 4(5-Chloro-2-[(E)-3-[(R)-4-(4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl]-phenylethynyl)-4-hydroxypiperidine-1-carboxylic acid tert butyl ester, (E)-3-[4-Chloro-2-(4-hydroxypiperidin-4-ylethynyl)-phenyl]-1-[(R)-4-(4-fluorobenzyl)-2-methylpiperazin-1yl]-propenone, (E)-3-[2-(3-Amino-3-methylbut-1-ynyl-4-Chlorophenyl]-1-[(R)-4-(4fluorobenzyl)-2-methylpiperazin-1-yl]-propenone, (E)-3-[4-Chloro-2-(3-dimethylaminoprop-1-ynyl)-phenyl]-1[4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-propenone, (E)-3-[4-Chloro-2-(3-hydroxy-3-methylbut-1-ynyl)-phenyl]-1-[4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-propenone, N-(3-[(E)-3[(R)-4-(4-Fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl]-naphthalen-2-yl)-acetamide, (3-[(E)-3-[(R)-4-(4-fluorobenzyl)methylpiperazin-1yl]-3--oxopropenyl]-naphthalen-2-yl)-urea, N-(3-[(E)-3-[(R)-4-(4-Fluorobenzyl)-2-methylpiperazin-1yl]-3-oxopropenyl]-naphthalen-2-yl)-N′-cyanoguanidine, N-(4-Chloro-2-[(E)-3-[4-(4fluorobenzyl)-2-methylpiperazin-1yl]-3-oxopropenyl]phenyl)-N′-cyanoguanidine, N-(4-Chloro-2-[(E)-3-[4-(4fluorobenzyl)-2-methylpiperazin-1yl]-3-oxopropenyl]-phenyl)-acetamide, N-(6-[(E)-3-[(R)-4-(4-Fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl]-quinolin-7-yl)-acetamide, (6-[(E)-3-[(R)-4-(4-Fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl]-quinolin-7-yl)-urea, N-(7-[(E)-3-[(R)-4(4-Fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl)-quinolin-6-yl)-acetamide, 2-Dimethylamino-N-(7-[(E)-3-[(R)-4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl]-quinolin-6-yl)-acetamide, N-(7-[(E)-3-[(R)-4-(4-Fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl]-quinolin-6-yl)-methanesulfonamide, N-(5-Chloro-2-[(E)-3-[(2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazin-1-yl]-3-oxopropenyl]-phenyl)-cyanoguanidine, N-(5-Chloro-2-[(E)-3-[(2R,5S)-4-(4 -fluorobenzyl)2,5-dimethylpiperazin-1-yl]-3-oxopropenyl ]-2-dimethylacetamide, N-(5-Chloro-2-[(E)-3-[(2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazin-1-yl]-3-oxopropenyl]-phenyl)-methanesulfonamide, N-(5-Chloro-2-[(E)-3-[(2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazin-1-yl]-3-oxopropenyl]-4-methoxyphenyl)-acetamide, N-(5-Chloro-2-[(E)-3-[(3R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazin-1-yl]-3-oxopropenyl]-4-methoxyphenyl)-methanesulfonamide, N-(5-Chloro-2-[(E)-3-(R)-4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl)-4-(2-methoxyethoxy)-phenyl]-acetamide, N-(5-Chloro-2-[(E)-3-(R)-4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl]-4-morpholin-4-yl-phenyl)-acetamide, N-(5-Chloro-2-{(E)-3-[(R)-2-ethyl-4-(4-fluorobenzyl)-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-acetamide, (5-Chloro-2-{(E)-3-[(R)-2-ethyl-4-(4-fluoro-benzyl)-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-urea, N-(5-Chloro-4-ethoxy-2-{(E)-3-[(R)-4-(4-fluorobenzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-acetamide, (5-Chloro-4-ethoxy-2-{(E)-3-[(R)-4-(4-fluorobenzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-urea, N-(5-Chloro-4-ethoxy-2-{(E)-3-[(R)-4-(4-fluorobenzyl)-2-methyl-piperazin-1-yl ]-3-oxo-propenyl}-phenyl)-methanesulfonamide, 5-Oxo-pyrrolidine-2-carboxylic acid (5-chloro-4-ethoxy-2-{(E)-3-[®-4-(4-fluorobenzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-amide, N-(5-Chloro-2-{(E)-3-[(S)-4-(4-fluoro-benzyl)-2-hydroxymethyl-piperazin-1-yl]-3-oxo-propenyl}-4-methoxy-phenyl)-acetamide, N-(5-Chloro-2-{(E)-3-[(S)-4-(4-fluoro-benzyl)-2-hydroxymethyl-piperazin-1-yl]-3-oxo-propenyl}-4-methoxy-phenyl)-methanesulfonamide, (5-Chloro-2-{(E)-3-[(S)-4-(4fluoro-benzyl)-2-hydroxymethyl-piperazin-1-yl]-3-oxo-propenyl}-4-methoxy-phenyl)-urea, 5-Oxo-pyrrolidine-2-carboxylic acid (5-chloro-2-{(E)-3-[(S)-4-(4-fluoro-benzyl)-2-hydroxymethyl-piperazin-1-yl]-3-propenyl}-4-methoxy-phenyl)-amide, N-(5-chloro-2-{(E)-3-[(S)-4-(4-flouro-benzyl)-2-hydorxymethyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)acetamide, N-(2-{(E)-3-[(R)-2-Aminomethyl-4-(4-fluoro-benzyl)-piperazin-1-yl-3-oxo-propenyl}-5-chloro-phenyl)-acetamide, N-(5-Chloro-2-{(E)-3-[(S)-4-(4fluoro-benzyl)-2-((S)-1-hydroxy-ethyl)-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-acetamide, N-(2-{(E)-3-[(S)-2-Acetyl-4-(4-fluoro-benzyl)-piperazin-1-yl]-3-oxo-propenyl}-5-chloro-phenyl)-acetanide, N-{5-Chloro-2-[(E)-3-((S)-4-(4-fluoro-benzyl)-2-{1-[hydroxyimino]-ethyl}-piperazin-1-yl)-3-oxo-propenyl}-acetamide, N-(2-{(E)-3-[(2S,5S)-2-Benzyloxymethyl-4-(4-fluoro-benzyl)-5-methyl-piperazin-1-yl]-3-oxo-propenyl}-5-chloro-phenyl)-acetamide, (S)-1-Acetyl-pyrrolidine-2-carboxylic acid (5-chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-4-methoxy-phenyl)-amide, (S)-1-Isopropyl-pyrrolidine-2-carboxylic acid (5-chloro-2-{(E)3-[(R)4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-4-methoxy-phenyl)-amide, (R)-1-isopropyl-pyrrolidine-2-carboxylic acid (5-chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-4-methoxy-phenyl)-amide, (2S, 4R)-1-Acetyl-4-hydroxy-pyrrolidine-2-carboxylic acid (5-chloro-2-{(E)-3[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl}-3-oxo-propenyl}-4-methoxy-phenyl)-amide, (E)-3-(4-Chloro-2-morpholin-4-ylmethyl-phenyl)-1-[4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-propenone, 1-(5-Chloro-2-{(E)-3-[4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-benzyl)-pyrrolidin-2-one, (E)-3-(4-Chloro-2-[1,2,4]triazol-1-ylmethyl-phenyl)-1-[4-(4fuoro-benzyl)-2-methyl-piperazin-1-yl]propenone, (E)-3-[4-Chloro-2-(4-methyl-piperazin-1-ylmethyl)-phenyl]-1-[4-(4-fluoro-benzyl-2-methyl-piperzin-1-yl]-propenene, (E)-3-[2-(4-Acethyl-piperazin-1-ylmethyl)-4-chloro-phenyl]-1-[4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-propenone, (E)-3-[4-Chloro-2-(4-isopropyl-pioerazin-1-ylmethyl)-phenyl]-1-[(R)-4-(4fluoro-benzyl)-2-methyl-piperazin-1-yl]-propenone, 1-(5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-benzyl)3-oxa-1-aza-spiro[4,4]nonan-2one, 3-(5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-benzyl)-5,5-dimethyl-imidazolidine-2,4dione, 3-(5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3oxo-propenyl}-benzyl)-1-methyl-imidazolidine-2,4-dione, (E)-3-[4-Chloro-2(5-methyl-tetrazol-1-ylmethyl)-phenyl]-1-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-propenone, 5-Chloro-2-{(E)-3-[(R)4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-N-methoxy-N-methyl-benzamide, 5-Chloro-2-{(E)-3-[4-(4fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-benzoic acid methyl ester, (5-Chloro-2-{(E)-3-[4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-acetic acid methyl ester, (5-Chloro-2-{(E)-3-[4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-benzoic acid, (5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-benzoic acid, (E)-3-[4-Chloro-2-(4-methyl-piperazin-1-carbonyl)-phenyl]-1-[4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-propenone, 5-Chloro-2-{(E)-3-[4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-N-isopropyl-benzamide, 5-Chloro-2-{(E)-3-[4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-N-(1-methyl-piperidin-4-yl)-benzamide, N-(1-Benzyl-piperidin-4-yl)-5-chloro-2-{(E)-3-[4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3oxo-propenyl}-benzamide, 4-(5-Chloro-2-{(E)-3-[4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-benzoylamino)-piperidine-1-carboxylic acid ethyl ester, (2S,4R)-1-(5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3oxo-propenyl}-benzoyl)-4hydroxy-pyrrolidine-2-carboxylic acid methyl ester, (E)-3-[4-Chloro-2-((R)-3-dimethylamino-pyrrolidine-1-carbonyl)-phenyl]-1-[(R)-4-(4-fluoro-benzyl)-2methyl-piperazin-1-yl]-propenone, (E)-3-[4-Chloro-2-((S)-3-dimethylamino-pyrrolidine-1-carbonyl)-phenyl]-1-[(R)-4-(4-fluoro-benzyl)-2methyl-piperazin-1-yl]-propenone, (E)-3-[2-(4-Acetyl-piperazine-1-carbonyl)-4-Chloro-phenyl]-1-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-propenone, N-(5-Chloro-2-{(E)-3-[4-(4-chloro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-acetamide, N-(5-Chloro-2-{(E)-3-[4-(3-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-acetamide, N-(5-Chloro-2-{(E)-3-[4-(2,4-difluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-acetamide, N-(5-Chloro-2-{(E)-3-[4-(4-cyano-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-acetamide, N-(5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-prop-enyl}-4-methoxy-phenyl)-acetamide, N-(5-Chloro-4-fluoro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1yl]-3-oxo-propenyl}-phenyl)-acetamide, (5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-4-methoxy-phenyl)-urea, N-(5-Chloro-4-fluoro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-methanesulfonamide, (5-Chloro-4-fluoro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-urea, (5-Chloro-4-cyano-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-acetamide, (5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-4-trifluoromethoxy-phenyl)-acetamide, (5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-4-trifluoromethoxy-phenyl)-urea, N-(5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-4-isobutoxy-phenyl)-acetamide, N-(5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-4-isobutoxy-phenyl)-acetamide, 3-(5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-4-methoxy-phenyl)-5,5-dimethyl-imidazolidine-2,4-dione, 3-(5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-4-methoxy-phenyl)-imidazolidine-2,4-dione, 3-(5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-4-methoxy-phenyl)-1,3-diaza-spiro[4,4]nonane-2,4-dione, 3-(5-Chloro-4-fluoro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-1,3-diaza-spiro[4,5]decane-2,4-dione, 3-(5-Chloro-4-fluoro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-phenyl)-5,5-dimethyl-imidazolidine-2,4-dione, Morpholine-4-carboxylic acid (5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-4-methoxy-phenyl)-amide, Pyrrolidine-1-carboxylic acid (5-chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-3-oxo-propenyl}-4-methoxy-phenyl)-amide, 5-Chloro-2-{(E)-3-[(R)-4-(4-fluoro-benzyl-2-methyl-piperazin-1-yl]-3-oxo-proneny}-4-methoxy-benzoic acid methyl ester, and (E)-3-[-2-(4-Acetyl-piperazine-1-carbonyl)-4-chloro-5-methoxy-phenyl]-1-[(R)-4-(4-fluoro-benzyl)-2-methyl-piperazin-1-yl]-propenone, or a pharmaceutically acceptable salt, or ester thereof. |
| Claim: | 4. A compound of formula III or a pharmaceutically acceptable salt or ester thereof, [chemical expression included] wherein R′ 1 is as herein before defined; R′ 2 and R′ 7 are hydrogen, cyano, halo, butadienyl, methoxy, ethoxy, 2-methoxyethoxy, morpholino, trifluoromethoxy, 2-methylpropoxy, 2-propoxy; R′ 5 and R′ 6 are independently selected from the group consisting of hydrogen and lower alkyl, acetyl. |
| Claim: | 5. A pharmaceutical composition comprising a compound according to claim 1 in association with a pharmaceutically acceptable diluent or carrier. |
| Claim: | 6. A compound of claim 1 selected from the group consisting of: N-(5-Chloro-2-[(E-)3-[(R)-4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl]phenyl)-N′-cyanoguanidine, N-(5-Chloro-2-[(E)-3-[(R)-4-(4-fluorobenzyl)2-methylpiperazin-1yl]-3-oxopropenyl]phenyl)-acetamide N-(5-Chloro-2-[(E)-3-[(S)-4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl]phenyl)-acetamide, (5-Chloro-2-[(E)-3-[(R)-4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl]-phenyl)-urea, (5-Chloro-2-[(E)-3-[(S)-4-(4-fluorobenzyl)-2-methylpiperazin-1-yl]-3-oxopropenyl]-phenyl)-urea, when R′ 1 is —C≡C—R′ 10 , R′ 10 is optionally substituted methyl, isopropyl or piperidinyl; when R′ 1 is —C═C—R′ 10 , R′ 10 is optionally substituted by hydrogen or amine; when R′ 1 is —C═C—R′ 10 , R′ 10 is optionally substituted piperidinyl, when R′ 1 is —C═C—R′ 10 , R′ 10 is optionally substituted by hydroxy, methyl; when R′ 1 is —N—C—S—R′ 10 the C atom is substituted by =N—C≡N or [chemical expression included] when R′ 1 —N—C—S—R′ 10 , R′ 10 is optionally substituted methyl, when R′ 1 is —N—C—S—R′ 10 , R′ 10 is optionally substituted by hydrogen; when R′ 1 is —C—R′ 10 the C atom is optionally substituted by oxo, when R′ 1 —C—R′ 10 , R′ 10 is 3-oxa-1-aza-spiro[4,4]nonan-2-one, hydroxy, optionally substituted pyrrolidinyl, morpholino, piperazinyl, formic acid methyl ester, [1,2,4]triazol, imidazolidinyl, tetrazolyl, —N(CH 3)—OCH 3 or methoxy; when R′ 1 is —C—R′ 10 , R′ 10 is optionally substituted by hydrogen, oxo, methyl, acetyl, isopropyl, methoxy, hydroxy, formic acid methyl ester, dimethylamino or ethanone; the optional substituents on R′ 10 are one or more substituents independently selected from the group consisting of hydrogen, or optionally substituted oxy, lower alkyl, carbonyl, amino; wherein the optionally substituted substituents are optionally substituted once or more by a substituent independently selected from the group consisting of hydrogen, optionally substituted oxy; or optionally substituted lower alkyl. |
| Current U.S. Class: | 51425/503 |
| Patent References Cited: | 4742062 May 1988 Ohtaka et al. 7098212 August 2006 Blumberg et al. 0 209 843 January 1987 2000 086603 March 2000 |
| Other References: | Paten Abstracts of Japan vol. 2000 No. 06 (2000) & JP 2000 086603 (Yoshitomi Pharm) (2000). cited by other |
| Assistant Examiner: | Sackey, Ebenezer |
| Primary Examiner: | Wilson, James O |
| Attorney, Agent or Firm: | Cross, Sophie Binet |
| رقم الانضمام: | edspgr.07645760 |
| قاعدة البيانات: | USPTO Patent Grants |
| الوصف غير متاح. |